NPI registry status
Active
2026 NPPES data Research Study Specialist NPI 1194973867 M.D.
Verify on CMS → George Freeman, M.D.
Research Study Specialist in Newport News, Virginia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 508 in Research Study Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
12
Medicare Part D claims · Research Study Specialist avg: 922
Industry payments
$35
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
George Freeman, M.D. filed 12 Medicare Part D claims in 2024 as a Research Study Specialist in Newport News, Virginia.
- 12
- Part D claims, 2024
- $35
- industry payments (Sunshine Act)
- ≥0th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about George Freeman, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1194973867), first enumerated 09/05/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 12 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Industry payment transparency
$35 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1194973867 · Research Study Specialist
NPI-10 · ENUM-MID · TAX-NARROW · RX-TRACE · BOOK-THIN · PHOTO-ENUM
- NPI-10 1194973867
- ENUM-MID 2008
- TAX-NARROW 508
- RX-TRACE 12
- BOOK-THIN 8 in Virginia
- PHOTO-ENUM Karen Quigley · 2008
George Freeman, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
12 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about George Freeman, M.D.?
Quality data not reportedPrimary specialty
Research Study Specialist
Medicare Part D claims
12 99% vs specialty avg
Specialty distribution in Virginia
How Research Study Specialist compares to other specialties among Virginia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Research Study Specialist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1194973867 |
|---|---|
| Specialty | Research Study Specialist |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/05/2008 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for George Freeman, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$35
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
12
Total Claims
$429
Total Drug Cost
N/A
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 23.533
- Total Day Supply
- 631
- Brand Drug Cost
- $0
- Generic Drug Cost
- $429
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 0.72
Research Study Specialist Overview
How George Freeman, M.D. fits within the Research Study Specialist landscape nationally.
508
Research Study Specialist Providers in US
42
States with Research Study Specialist
922
Avg Claims per Provider
George Freeman, M.D.'s 12 claims are below the specialty average of 922.
Nationwide Research Study Specialist peers with similar MIPS or enrollment year
Two federal-record peer sets for Freeman, both outside Virginia so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Research Study Specialist Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as Freeman.
One of 8 Research Study Specialist providers enrolled in Virginia, 5 are shown here.
Tiffany Boykins
Chesapeake, VA
William Davis
North Chesterfield, VA
Kevin Fields
M.S., C.R.C.
Richmond, VA
Dr. Ashraf Gorgey
PT, PHD
Richmond, VA
Morgan Kearney
Falls Church, VA
Compare Research Study Specialist nationally: see state-by-state distribution →
Frequently Asked Questions
What is George Freeman, M.D.'s specialty? ▼
George Freeman, M.D. specializes in Research Study Specialist and practices in Newport News, Virginia. Credentials: M.D..
How much does George Freeman, M.D. prescribe under Medicare Part D? ▼
In 2024, George Freeman, M.D. wrote 12 Medicare Part D claims totaling $429 in drug costs for N/A beneficiaries.
Where is George Freeman, M.D. located? ▼
George Freeman, M.D. is located at 11747 JEFFERSON AVE, Newport News, VA, 23606. Phone: (757) 591-8100.
What is George Freeman, M.D.'s NPI number? ▼
George Freeman, M.D.'s National Provider Identifier (NPI) is 1194973867, issued on 09/05/2008.
How many Research Study Specialist providers are there in the US? ▼
There are 508 Research Study Specialist providers across 42 states in the US. The average Research Study Specialist provider writes 922 Medicare Part D claims per year.
Does George Freeman, M.D. accept Medicare? ▼
George Freeman, M.D. appears in CMS Medicare data with 12 Part D claims and N/A Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify George Freeman, M.D.'s credentials? ▼
George Freeman, M.D.'s NPI is 1194973867 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.